Results 191 to 199 of about 642,659 (199)

PCSK9 inhibitor in acute ischemic stroke patient receiving mechanical thrombectomy: early outcomes and safety. [PDF]

Front Neurol
Kim J, Hong U, Yoon CW, Bae JW, Rha JH, Park HK.   +5 more
europepmc   +1 more source

Effect of PCSK9 inhibitor on early neurological deterioration in acute ischemic stroke patients with a history of coronary heart disease: a study protocol for a randomized controlled trial in Dalian, China. [PDF]

Trials
Gong X, Yu X, Pu L, Jiao Y, Liu L, Cao H, Ji X.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment

Expert Opinion on Investigational Drugs, 2023
John R Burnett, Amanda Hooper
exaly  

The Association Between PCSK9 Inhibitor Use and Sepsis: A Systematic Review and Meta-Analysis of 20 Double-Blind, Randomized, Placebo-Controlled Trials

American Journal of Medicine, 2023
Zhen Zhou
exaly  

Early use of PCSK9 inhibitor therapy after heart transplantation from a hepatitis C virus positive donor

Journal of Clinical Lipidology, 2021
Eugenia Gianos, Laurence Sperling, David Majure   +2 more
exaly  

Treatment with PCSK9 Inhibitor Evolocumab Improves Vascular Oxidative Stress and Arterial Stiffness in Hypercholesterolemic Patients with High Cardiovascular Risk

Antioxidants, 2023
Federica Fogacci, Silvana Hrelia, Patrizia Simoni   +2 more
exaly  

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia

Journal of the American College of Cardiology

exaly  

Berberine: A Multi-Target Natural PCSK9 Inhibitor with the Potential to Treat Diabetes, Alzheimer’s, Cancer and Cardiovascular Disease

Current Reviews in Clinical and Experimental Pharmacology
Mehrnoosh Hashemzadeh
exaly